GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Other Gross PPE

Acticor Biotech (XPAR:ALACT) Other Gross PPE : €0.00 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech Other Gross PPE?

Acticor Biotech's Other Gross PPE for the quarter that ended in Jun. 2023 was €0.00 Mil.

Acticor Biotech's quarterly Other Gross PPE increased from Jun. 2022 (€0.00 Mil) to Dec. 2022 (€0.03 Mil) but then declined from Dec. 2022 (€0.03 Mil) to Jun. 2023 (€0.00 Mil).

Acticor Biotech's annual Other Gross PPE declined from Dec. 2020 (€0.00 Mil) to Dec. 2021 (€-0.12 Mil) but then increased from Dec. 2021 (€-0.12 Mil) to Dec. 2022 (€0.03 Mil).


Acticor Biotech Other Gross PPE Historical Data

The historical data trend for Acticor Biotech's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech Other Gross PPE Chart

Acticor Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Gross PPE
Get a 7-Day Free Trial 0.29 0.29 - -0.12 0.03

Acticor Biotech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Other Gross PPE Get a 7-Day Free Trial Premium Member Only 0.32 -0.12 - 0.03 -

Acticor Biotech Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Acticor Biotech (XPAR:ALACT) Business Description

Traded in Other Exchanges
Address
82 Avenue du Maine, Wojo Building, Paris, FRA, 75014
Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines